Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06547645 · ClinicalTrials.gov registry record · NA

Skilled Nursing Facility at Home Trial

A NA study of Rehabilitation and Skilled Nursing Facility, sponsored by University of Massachusetts, Worcester.

Recruiting
Registry status
NA
Development phase
650
Enrollment target
2
Study locations

NCT06547645: Recruiting NA study of Rehabilitation and Skilled Nursing Facility, sponsored by University of Massachusetts, Worcester.

NCT06547645 is a NA study of Rehabilitation and Skilled Nursing Facility that is actively recruiting participants, run by University of Massachusetts, Worcester. The registered enrollment target is 650 participants, above the 122-participant average among 15 other Rehabilitation trials with a reported enrollment target (433% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06547645, a NA study of Rehabilitation and Skilled Nursing Facility, is actively recruiting participants, sponsored by University of Massachusetts, Worcester.

RECRUITING
Registry status
NA
Development phase
650 participants
Enrollment target
2
Study locations

Study Summary

Skilled Nursing Facility at Home is a multicenter randomized control trial that aims to evaluate a home-based model of providing post-acute care (PAC). We will enroll 650 hospitalized patients who require rehabilitation and/or skilled-nursing support upon discharge and randomly assign them to an intervention (home-based PAC) or control arm (facility-based PAC). Our design includes two different health systems in Massachusetts: Baystate Health and UMass Memorial Health. We will perform 1:1 randomization between the intervention and control arm using a permuted block design, with stratification by clinical site and payor group. The primary outcome of the trial will be the difference in hospital readmission and mortality rates from the time of enrollment to 30 days after enrollment. Secondary clinical, functional, and cost outcomes include length of stay in PAC, difference in health-related quality of life (HRQoL), and healthcare cost and utilization.

Primary Outcome

Hospital readmission rates and mortality rates between the intervention and control groups in the first 30 days after enrollment

Interventions

  • OTHER Sub-Acute Rehab at Home

Study Locations (2)

Massachusetts

  • Baystate Medical Center - Springfield
  • UMass Memorial Medical Center - Worcester

Trial Details

FieldValue
Enrollment Target 650 participants
Start Date 2024-08-26
Est. Completion 2027-05
Phase NA

What NCT06547645 shows while recruiting

NCT06547645 is an interventional study that assigns participants to a tested intervention. The registered 650 participants enrollment target is mid-sized for trials with a published cap, above the 122-participant average among 15 other Rehabilitation trials with a reported enrollment target (433% higher).

The record links to 3 conditions, with Rehabilitation appearing as the primary indexed condition, and to 1 intervention - of which Sub-Acute Rehab at Home is the first listed.

NCT06547645 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06547645 about?

NCT06547645 is a clinical study titled "Skilled Nursing Facility at Home Trial". Skilled Nursing Facility at Home is a multicenter randomized control trial that aims to evaluate a home-based model of providing post-acute care (PAC). We will enroll 650 hospitalized patients who require rehabilitation and/or skilled-nursing support upon discharge and randomly assign them to an int...

What is the current status of trial NCT06547645?

This trial is currently recruiting. It is a NA study. The enrollment target is 650 participants. The study started on 2024-08-26. Estimated completion is 2027-05.

What conditions does trial NCT06547645 study?

This clinical trial studies the following conditions: Rehabilitation, Skilled Nursing Facility, Home Based Care.

What interventions are being tested in trial NCT06547645?

The interventions under investigation include: Sub-Acute Rehab at Home (OTHER).

Who is sponsoring clinical trial NCT06547645?

This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06547645 being conducted?

This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Rehabilitation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06547645's enrollment target sits among peer trials

650 1st of 15 higher than 15 of 15 other Rehabilitation trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Rehabilitation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02934477 · 650 participants

    Prospective Assessment of Allogeneic Hematopoietic Cell Transplantation in Patients With Myelofibrosis

  • NCT04579120 · 650 participants

    Neuroimaging in Healthy Aging and Senile Dementia (HASD_IND)

  • NCT04875702 · 650 participants · Phase 4

    Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout

  • NCT05046600 · 650 participants

    Registry of Arthrex Hand and Wrist Products

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06547645, the US trial registry maintained by the National Library of Medicine. NCT06547645 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.